The United States spends more per capita on health care than any other nation, but there are large disparities in health outcomes in relation to race, community of residence, and individual and community socioeconomic factors. Some American communities are falling behind the best performing nations in life expectancy, while rates of obesity, asthma and other diseases continue to rise. 1
area, home to approximately 5,000 GSK employees, is a natural choice for the first stop in this multi-city program due to its significant health challenges. Two-thirds of adults and 40 percent of children in
are overweight or obese.
One quarter of adults in the city smoke, and smoking-related complications are a leading cause of death.
The number of residents with chronic health conditions — such as high blood pressure and diabetes — increased over the past decade and remains significantly higher than the national average.
These problems persist in spite of the vibrant life sciences industry, leading academic and medical institutions and community-based non-profit and city efforts that have demonstrated real success.
Additional information about "A Conversation on Community Health," hosted by The Atlantic -
town hall will be available via live stream from 3 –
5 pm ET
Monday, September 24
Over the course of the three city program,
will be exploring the many facets of community health through an ongoing special report available at
Join the conversation on Twitter @GSKUS or @Atlantic_Live, #HealthyCommunity.
– one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information go to
, follow us on
or visit our
Kulkarni et al. Population Health Metrics 2011, 9:16
City of Philadelphia
, Mayor Nutter's Soda Summit Address,
June 7, 2012
Philadelphia Department of Public Health, Tobacco Control Program:
16 July 15
Pew Research Initiative.
2011 The State of the City. The Pew Charitable Trusts 2011: 51-58.
Aug. 30, 2012
Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2011.